Personalised chemotherapy, targeted therapy and immunotherapy.
Medical oncology has changed beyond recognition in the last fifteen years. Where once chemotherapy was a blunt instrument, today’s medical oncologist designs treatment around the specific biology of your tumour — using targeted drugs that home in on the mutations driving the cancer, and immunotherapies that train your own immune system to recognise and destroy cancer cells. The result is more cancers controlled or cured, with fewer side effects, more days at home and a better quality of life.
Medical oncology is involved at the time of cancer diagnosis to plan the treatment sequence. If you have been diagnosed with cancer — solid tumour, blood cancer or lymphoma — a medical oncologist should be part of your team from the start. Second opinions are welcome and often valuable when complex treatment decisions are involved.
Cytotoxic drugs delivered as outpatient infusions or oral therapy, given alone or alongside surgery and radiation.
Drugs that block specific molecular pathways — HER2 in breast cancer, EGFR in lung cancer, BCR-ABL in CML and many more.
Checkpoint inhibitors and CAR-T cell therapies that unleash the immune system against cancer.
Tamoxifen, aromatase inhibitors and androgen-deprivation therapy for hormone-driven cancers.
Treatment chosen by the specific genomic profile of the tumour.
Anti-emetics, growth factors, transfusions and nutritional support that make treatment tolerable.
Access to investigational therapies for selected patients.
Treatment begins with a detailed planning consultation — your diagnosis, stage, treatment goals, schedule and side-effect profile are discussed in detail. Most chemotherapy is delivered as a day-care infusion in a dedicated chair or bed, typically every two to three weeks for several cycles. Oral therapies are dispensed for home use with clear instructions. Side effects are monitored proactively and managed with anti-nausea medicines, growth factors and other supportive care. Imaging is repeated periodically to assess response.
Most patients continue their daily activities through treatment, with rest days planned around infusions. Hair loss, fatigue, nausea and changes in appetite are common but manageable. Blood counts are monitored regularly. After completion, a structured surveillance plan with clinical review, blood tests and imaging continues for years. Survivorship clinics support long-term recovery — managing late effects, fertility, return to work and emotional wellbeing.
Medaura connects you with surgeons and physicians who have trained at India’s top medical institutions and continue to publish, teach and innovate in their fields. Every recommendation we make is grounded in current international guidelines and our doctors’ direct clinical experience. We coordinate appointments, second opinions, diagnostic workups, financial estimates and travel logistics for patients from across India and abroad — so you can focus on getting better, not on navigating a fragmented healthcare system.
A coordinator responds within one business day with next steps, costs and timeline.
Get quick, reliable information about treatments, appointments, services, and patient care.
Some chemotherapy regimens cause hair loss; others do not. Targeted and hormone therapies usually do not. Scalp cooling can reduce hair loss for some regimens.
Many patients continue working, often on a reduced schedule. Energy varies through the treatment cycle.
It depends on the tumour type and biomarker status (e.g. PD-L1, MSI). Your oncologist will explain whether it is appropriate.